Sector Charles River Laboratories International, Inc. Berne S.E.
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 184.25 CHF | -1.01% |
|
+4.62% | - |
| 20/07 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
| 14/07 | BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.14% | -0.67% | +3.82% | +16.06% | +4.17% | -0.88% | +11.02% | -18.29% | +206.96% | 47.74B | |
| -3.15% | -0.29% | -5.12% | +26.18% | +129.44% | +390.47% | +610.81% | +517.40% | - | 39.98B | |
| +0.75% | +2.98% | +13.17% | +10.07% | +8.02% | +11.43% | +45.77% | +4.94% | +1,097.71% | 36.23B | |
| +12.31% | +18.95% | +24.08% | +50.86% | +6.40% | +21.27% | +6.05% | -2.26% | +207.79% | 35.59B | |
| -0.73% | +2.78% | +6.93% | -8.69% | +2.91% | +4.65% | +41.16% | -18.11% | +147.26% | 27.91B | |
| -2.29% | -2.83% | -5.97% | +11.66% | - | - | - | - | - | 16.71B | |
| -1.25% | +9.77% | +9.14% | +42.46% | +3.91% | +28.81% | +129.03% | +234.07% | - | 16.45B | |
| +2.39% | -1.64% | +0.50% | +14.66% | +9.81% | +4.74% | +9.95% | -31.52% | +105.21% | 13.21B | |
| +6.93% | +8.87% | +4.86% | +76.99% | -0.45% | -4.36% | -28.06% | -21.22% | +130.52% | 12.93B | |
| +0.58% | +0.58% | +1.61% | +34.64% | +22.50% | +23.05% | -14.02% | -39.55% | +160.14% | 11.16B | |
| -3.89% | -7.40% | +30.61% | +13.87% | -9.63% | +90.88% | +519.59% | +250.40% | +2,496.66% | 11.1B | |
| -0.14% | -0.07% | +1.12% | +57.08% | +77.66% | +238.12% | +546.27% | - | - | 10.08B | |
| -2.71% | +1.18% | +43.31% | +28.61% | +32.68% | +25.73% | +45.86% | -54.49% | - | 9.54B | |
| -3.07% | +1.74% | -32.68% | -24.32% | -31.34% | +31.94% | +36.52% | +43.97% | +88.35% | 9.25B | |
| -2.96% | -5.21% | -1.70% | +28.16% | +38.11% | +143.12% | +392.03% | +80.39% | - | 9.05B | |
| -7.61% | -7.66% | -16.27% | -8.82% | -0.41% | +427.44% | +1,896.73% | +23.77% | - | 8.8B | |
| -3.89% | -4.18% | -3.60% | +48.33% | +80.99% | +93.65% | +76.08% | +96.51% | +5.22% | 8.79B | |
| -0.22% | -2.12% | +11.30% | +33.76% | +55.00% | +140.63% | +609.17% | +188.10% | - | 8.72B | |
| +1.78% | +3.11% | +5.03% | +22.84% | -11.72% | -22.13% | -20.54% | -27.47% | +53.88% | 8.5B | |
| Average | -0.36% | +1.34% | +4.74% | +24.97% | +23.22% | +91.59% | +272.97% | +72.16% | +427.24% | 17.99B | |
| Weighted average by Cap. | +0.56% | +2.10% | +6.02% | +23.65% | +26.29% | +87.62% | +208.61% | +88.85% | +427.39% |
- Stock Market
- Stocks
- CRL Stock
- RV6 Stock
- Sector Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions
